title: Nano and microtechnologies for the delivery of oligonucleotides with gene silencing properties.
abstract: Oligonucleotides (ONs) are synthetic fragments of nucleic acid designed to modulate the expression of target proteins. DNA-based ONs (antisense, antigene, aptamer or decoy) and more recently a new class of RNA-based ONs, the small interfering RNAs (siRNAs), have gained great attention for the treatment of different disease states, such as viral infections, inflammation, diabetes, and cancer. However, the development of therapeutic strategies based on ONs is hampered by their low bioavailability, poor intracellular uptake and rapid degradation in biological fluids. The use of a non-viral carrier can be a powerful tool to overcome these drawbacks. Lipid or polymer-based nanotechnologies can improve biological stability and cellular uptake of ONs, with possibility of tissue and/or cellular targeting. The use of polymeric devices can also produce a prolonged release of the ON, thus reducing the need of frequent administrations. This review summarizes advantages and issues related to the main non-viral vectors used for ON delivery.
authors.affiliation: Dipartimento di Chimica Farmaceutica e Tossicologica, Facoltà di Farmacia, Università degli Studi di Napoli Federico II, Via D. Montesano 49, 80131 Naples, Italy. gderosa@unina.it
authors.forename: Giuseppe
authors.initials: G
authors.lastname: De Rosa
authors.forename: Maria Immacolata
authors.initials: MI
authors.lastname: La Rotonda
mesh_terms: D020868:Gene Silencing; D008081:Liposomes / Q000737:chemistry; D055616:Microtechnology / Q000379:methods*; D036103:Nanotechnology / Q000379:methods*; D009841:Oligonucleotides / Q000737:chemistry* / Q000235:genetics; D011108:Polymers / Q000737:chemistry; D034741:RNA, Small Interfering / Q000737:chemistry / Q000235:genetics
chemical_list: D008081:Liposomes; D009841:Oligonucleotides; D011108:Polymers; D034741:RNA, Small Interfering
references.citation: AAPS PharmSciTech. 2008;9(2):335-41
references.pmid: 18431646
references.citation: Oligonucleotides. 2009 Jun;19(2):163-8
references.pmid: 19441893
references.citation: Biomacromolecules. 2006 Jan;7(1):347-56
references.pmid: 16398535
references.citation: Biochem Biophys Res Commun. 2005 May 13;330(3):755-9
references.pmid: 15809061
references.citation: Curr Med Chem. 2004 Jan;11(2):179-97
references.pmid: 14754416
references.citation: Biochemistry. 1993 May 11;32(18):4855-61
references.pmid: 8490026
references.citation: Genes Dev. 2001 Jan 15;15(2):188-200
references.pmid: 11157775
references.citation: Biomaterials. 2007 Feb;28(6):1280-8
references.pmid: 17126901
references.citation: Biochim Biophys Acta. 1996 Jun 11;1281(2):139-49
references.pmid: 8664312
references.citation: Mol Ther. 2006 Apr;13(4):644-70
references.pmid: 16481219
references.citation: Brain Dev. 2008 May;30(5):313-20
references.pmid: 18358657
references.citation: J Gene Med. 2005 Jun;7(6):771-81
references.pmid: 15702489
references.citation: Nature. 2000 Mar 16;404(6775):293-6
references.pmid: 10749213
references.citation: J Control Release. 2000 Oct 3;69(1):197-207
references.pmid: 11018557
references.citation: J Nanosci Nanotechnol. 2007 Nov;7(11):3695-9
references.pmid: 18047039
references.citation: Genes Dev. 1999 Dec 15;13(24):3191-7
references.pmid: 10617568
references.citation: Arthritis Rheum. 2006 Jun;54(6):1867-77
references.pmid: 16729293
references.citation: J Gene Med. 2009 Mar;11(3):229-39
references.pmid: 19189285
references.citation: Bioconjug Chem. 2003 May-Jun;14(3):672-8
references.pmid: 12757394
references.citation: Biochim Biophys Acta. 1994 Oct 12;1195(1):115-23
references.pmid: 7918553
references.citation: Mol Pharm. 2009 May-Jun;6(3):659-68
references.pmid: 19267452
references.citation: Biochim Biophys Acta. 2001 Feb 9;1510(1-2):152-66
references.pmid: 11342155
references.citation: Bioconjug Chem. 1999 Nov-Dec;10(6):1068-74
references.pmid: 10563777
references.citation: Nature. 2006 Jan 5;439(7072):89-94
references.pmid: 16306938
references.citation: Nat Rev Drug Discov. 2004 Dec;3(12):1023-35
references.pmid: 15573101
references.citation: Eur J Pharm Biopharm. 1999 Mar;47(2):119-23
references.pmid: 10234535
references.citation: Biomaterials. 1994 Dec;15(15):1209-13
references.pmid: 7703316
references.citation: Int J Pharm. 2007 Feb 1;329(1-2):1-11
references.pmid: 17137734
references.citation: J Control Release. 2006 May 15;112(2):257-70
references.pmid: 16574264
references.citation: Biochimie. 2007 Oct;89(10):1245-51
references.pmid: 17619075
references.citation: Clin Cancer Res. 2006 Feb 15;12(4):1251-9
references.pmid: 16489081
references.citation: J Control Release. 2006 Oct 10;115(2):216-25
references.pmid: 16959358
references.citation: J Biochem. 2001 May;129(5):755-9
references.pmid: 11328598
references.citation: Drug Deliv. 2002 Jul-Sep;9(3):169-80
references.pmid: 12396734
references.citation: Ann N Y Acad Sci. 2006 Oct;1082:1-8
references.pmid: 17145918
references.citation: Antisense Nucleic Acid Drug Dev. 2000 Oct;10(5):369-80
references.pmid: 11079576
references.citation: Gene Ther. 2005 Mar;12(5):461-6
references.pmid: 15616603
references.citation: Drug Metab Dispos. 2004 Sep;32(9):983-92
references.pmid: 15319340
references.citation: Bioconjug Chem. 2007 Mar-Apr;18(2):456-68
references.pmid: 17326672
references.citation: Mol Ther. 2009 Jul;17(7):1225-33
references.pmid: 19401674
references.citation: Pharm Res. 2008 Dec;25(12):2972-82
references.pmid: 18709489
references.citation: Bioconjug Chem. 1998 Nov-Dec;9(6):805-12
references.pmid: 9815175
references.citation: Int J Pharm. 2003 Mar 18;254(1):89-93
references.pmid: 12615416
references.citation: Mol Ther. 2009 Jan;17(1):162-8
references.pmid: 18827803
references.citation: Bioconjug Chem. 2004 Jul-Aug;15(4):677-84
references.pmid: 15264853
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13859-64
references.pmid: 9811891
references.citation: J Pharm Pharmacol. 2001 Aug;53(8):1047-67
references.pmid: 11518015
references.citation: Pharm Res. 2006 Apr;23(4):770-81
references.pmid: 16572352
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5715-21
references.pmid: 17379663
references.citation: Int J Pharm. 2007 Mar 1;331(2):167-75
references.pmid: 17134859
references.citation: Nat Biotechnol. 2005 Aug;23(8):1002-7
references.pmid: 16041363
references.citation: Surg Today. 2007;37(7):575-83
references.pmid: 17593477
references.citation: Biomaterials. 2007 Mar;28(7):1434-42
references.pmid: 17141864
references.citation: Mol Microbiol. 1992 Nov;6(22):3343-53
references.pmid: 1484489
references.citation: J Drug Target. 1998;5(4):291-302
references.pmid: 9713978
references.citation: Biochem Biophys Res Commun. 1993 Dec 15;197(2):818-25
references.pmid: 8267621
references.citation: Drug Discov Today. 2006 Jan;11(1-2):67-73
references.pmid: 16478693
references.citation: Biomacromolecules. 2003 May-Jun;4(3):529-36
references.pmid: 12741766
references.citation: Bioconjug Chem. 2005 Jul-Aug;16(4):986-94
references.pmid: 16029041
references.citation: Bioconjug Chem. 2003 Nov-Dec;14(6):1122-32
references.pmid: 14624625
references.citation: Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5177-81
references.pmid: 10220439
references.citation: Biomaterials. 2007 Aug;28(22):3360-8
references.pmid: 17459468
references.citation: Crit Rev Ther Drug Carrier Syst. 2005;22(6):535-602
references.pmid: 16566705
references.citation: Nature. 2006 May 4;441(7089):111-4
references.pmid: 16565705
references.citation: Biochim Biophys Acta. 1992 Aug 14;1113(2):201-27
references.pmid: 1510997
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7297-301
references.pmid: 7638184
references.citation: Bioconjug Chem. 2001 Mar-Apr;12(2):280-90
references.pmid: 11312690
references.citation: Biochemistry. 2007 Apr 24;46(16):4785-92
references.pmid: 17391006
references.citation: Genet Vaccines Ther. 2008 Feb 15;6:7
references.pmid: 18279512
references.citation: J Drug Target. 1998;5(3):149-62
references.pmid: 9606005
references.citation: J Control Release. 2002 Dec 5;84(3):171-81
references.pmid: 12468220
references.citation: Bioconjug Chem. 2006 Sep-Oct;17(5):1209-18
references.pmid: 16984130
references.citation: J Control Release. 2006 May 30;112(3):369-81
references.pmid: 16644054
references.citation: Eur J Pharm Biopharm. 2000 Jul;50(1):101-19
references.pmid: 10840195
references.citation: Hum Gene Ther. 2008 Aug;19(8):795-806
references.pmid: 18647087
references.citation: Int J Biochem Cell Biol. 2003 Jan;35(1):22-31
references.pmid: 12467644
references.citation: Hum Gene Ther. 2006 Jan;17(1):117-24
references.pmid: 16409130
references.citation: Mol Pharm. 2006 Sep-Oct;3(5):579-88
references.pmid: 17009857
references.citation: Nature. 1998 Feb 19;391(6669):806-11
references.pmid: 9486653
references.citation: J Control Release. 2000 Nov 3;69(2):309-22
references.pmid: 11064137
references.citation: Biochim Biophys Acta. 1994 Dec 30;1196(2):201-8
references.pmid: 7841184
references.citation: Bioconjug Chem. 2003 Jan-Feb;14(1):247-54
references.pmid: 12526715
references.citation: Curr Drug Targets. 2003 Nov;4(8):599-602
references.pmid: 14577648
references.citation: J Control Release. 2008 Mar 20;126(3):274-80
references.pmid: 18237815
references.citation: Biomaterials. 2008 Feb;29(4):506-12
references.pmid: 17950838
references.citation: Gene Ther. 2002 Dec;9(23):1607-16
references.pmid: 12424613
references.citation: J Drug Target. 2000;8(5):319-34
references.pmid: 11328659
references.citation: Cancer Gene Ther. 2001 Jun;8(6):459-68
references.pmid: 11498766
references.citation: Biomacromolecules. 2007 Apr;8(4):1333-40
references.pmid: 17358077
references.citation: Bioconjug Chem. 2003 Jan-Feb;14(1):255-61
references.pmid: 12526716
references.citation: Med Chem. 2005 Mar;1(2):199-208
references.pmid: 16787315
references.citation: Mol Pharmacol. 1992 Jun;41(6):1023-33
references.pmid: 1352033
references.citation: Clin Cancer Res. 2004 Nov 1;10(21):7244-51
references.pmid: 15534098
references.citation: Hum Gene Ther. 2005 Nov;16(11):1307-17
references.pmid: 16259564
references.citation: J Pharm Sci. 2002 Mar;91(3):790-9
references.pmid: 11920765
references.citation: J Pharm Pharmacol. 2003 Sep;55(9):1199-206
references.pmid: 14604462
references.citation: J Biomed Mater Res A. 2008 Mar 1;84(3):777-84
references.pmid: 17635017
references.citation: Pharm Res. 2006 Aug;23(8):1868-76
references.pmid: 16845585
references.citation: Mol Ther. 2006 Oct;14(4):476-84
references.pmid: 16829204
references.citation: Prostate. 2008 Sep 15;68(13):1430-42
references.pmid: 18615483
references.citation: Eur J Pharm Biopharm. 2008 Sep;70(1):7-18
references.pmid: 18482831
references.citation: Am J Physiol Gastrointest Liver Physiol. 2007 Sep;293(3):G631-9
references.pmid: 17640975
references.citation: Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15549-54
references.pmid: 17875985
references.citation: Biosci Rep. 1995 Feb;15(1):47-53
references.pmid: 7647291
references.citation: Trends Biotechnol. 1990 Dec;8(12):340-4
references.pmid: 1366894
references.citation: Curr Med Chem. 2005;12(19):2193-214
references.pmid: 16178780
references.citation: J Control Release. 1999 Aug 5;60(2-3):149-60
references.pmid: 10425321
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11493-8
references.pmid: 8876163
references.citation: J Mol Biol. 2003 Apr 4;327(4):761-6
references.pmid: 12654261
references.citation: Eur J Pharm Biopharm. 2004 May;57(3):427-30
references.pmid: 15093589
references.citation: Nucleic Acids Res. 1998 Apr 15;26(8):2016-23
references.pmid: 9518498
references.citation: J Control Release. 2008 Oct 6;131(1):64-9
references.pmid: 18674578
references.citation: J Biomed Mater Res. 1997 Jun 15;35(4):525-30
references.pmid: 9189830
references.citation: Biophys J. 2004 Jul;87(1):609-14
references.pmid: 15240493
references.citation: J Drug Target. 2003;11(8-10):495-507
references.pmid: 15203918
references.citation: Pharmacol Res. 2009 Jul;60(1):33-40
references.pmid: 19427583
references.citation: Antisense Nucleic Acid Drug Dev. 1999 Oct;9(5):451-8
references.pmid: 10555152
references.citation: J Nanobiotechnology. 2009 Apr 07;7:1
references.pmid: 19351396
references.citation: Biochim Biophys Acta. 1998 Feb 16;1390(2):119-33
references.pmid: 9507083
references.citation: Pharm Res. 1998 Sep;15(9):1326-31
references.pmid: 9755881
references.citation: Mol Pharm. 2009 May-Jun;6(3):727-37
references.pmid: 19178144
references.citation: Eur J Pharm Sci. 2000 May;10(3):187-93
references.pmid: 10767596
references.citation: Pharm Res. 1996 Sep;13(9):1367-72
references.pmid: 8893276
references.citation: J Control Release. 2006 Nov 28;116(2):179-91
references.pmid: 16891028
references.citation: Bioconjug Chem. 2002 May-Jun;13(3):630-9
references.pmid: 12009955
references.citation: Science. 1990 Nov 16;250(4983):997-1000
references.pmid: 2237444
references.citation: Eur J Pharm Biopharm. 2005 Aug;60(3):327-34
references.pmid: 15894474